Article
Ligand-independent activation of the estrogen receptors alpha and beta by mutations of a conserved tyrosine can be abolished by antiestrogens.
Cancer research - 1 Mar 1998
Tremblay G B, Tremblay A, Labrie F, Giguère V
Abstract excerpt
It has recently been suggested that mutation of a conserved tyrosine to asparagine within the ligand-binding domain of the estrogen receptor (ER) alpha confers hormone-independent activation and insensitivity to antiestrogens (Q. X. Zhang et al., Cancer Res., 57: 1244-1249, 1997). In view of the...
Topics
- Animals
- COS Cells
- Estrogen Antagonists
- Estrogen Receptor alpha
- Estrogen Receptor beta
- Humans
- Ligands
- Mutation
- Receptors, Estrogen
- Signal Transduction
- Tyrosine
